Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as various products for ADHD symptoms. It provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, aripiprazole, atorvastatin calcium, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, Clarithromycin, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nitazoxanide, quetiapine, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide. The company also offers early and late phase drug development, process research and development, contract and API manufacturing, and custom chemicals and synthesis; and analytical development, regulatory support, chemistry, impurity profiling, isolation, discovery, identification and characterization, and project management services. It also exports its products. Ind-Swift Laboratories Limited was founded in 1995 and is based in Manimajra, India.
Ind-Swift Laboratories Dividend Announcement
• Ind-Swift Laboratories announced a annually dividend of ₹1.00 per ordinary share which will be made payable on 2011-10-26. Ex dividend date: 2011-09-20
• Ind-Swift Laboratories's trailing twelve-month (TTM) dividend yield is -%
Ind-Swift Laboratories Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2011-09-20 | ₹1.00 | annually | 2011-10-26 |
2010-09-16 | ₹1.00 | annually | 2010-10-22 |
2009-09-17 | ₹1.00 | annually | 2009-10-24 |
2008-09-18 | ₹1.00 | annually | 2008-11-01 |
2007-09-21 | ₹1.00 | annually | 2007-11-01 |
2006-09-22 | ₹1.50 | annually | 2006-11-01 |
2005-09-22 | ₹1.50 | annually | 2005-10-11 |
2004-09-23 | ₹1.00 | annually | 2004-10-10 |
Ind-Swift Laboratories Dividend per year
Ind-Swift Laboratories Dividend growth
Ind-Swift Laboratories Dividend Yield
Ind-Swift Laboratories current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Ind-Swift Laboratories stock? Use our calculator to estimate your expected dividend yield:
Ind-Swift Laboratories Financial Ratios
Ind-Swift Laboratories Dividend FAQ
Other factors to consider when evaluating Ind-Swift Laboratories as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Ind-Swift Laboratories stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Ind-Swift Laboratories's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Ind-Swift Laboratories publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Ind-Swift Laboratories distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Ind-Swift Laboratories are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Ind-Swift Laboratories sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Ind-Swift Laboratories distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Ind-Swift Laboratories declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Ind-Swift Laboratories's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Ind-Swift Laboratories's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.